• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 432624 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413791759 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413791759 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Momenta Pharmaceuticals Shares Sinking Lower, Down 1.4%

Published on Wed, 01/30/2013 - 13:24
By Adrienne Chilton

Momenta Pharmaceuticals (NASDAQ:MNTA) is one of today's biggest movers, down 1.4% to $12.87. The Dow Jones Industrial Average is now trading fractionally higher to 13,956 and the S&P is trading fractionally lower to 1,507.

Over the past year, Momenta Pharmaceuticals has traded in a range of $10.05 to $21.00 and is now at $12.87, 28% above that low. The 200-day and 50-day moving averages have moved 0.24% lower and 0.90% higher over the past week, respectively.

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Momenta Pharmaceuticals (NASDAQ:MNTA) has potential upside of 10.7% based on a current price of $12.87 and analysts' consensus price target of $14.25. The stock should hit resistance at its 200-day moving average (MA) of $13.57, as well as support at its 50-day MA of $11.59.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

McCormick & Co Earnings Hindsight: Down ...

When McCormick & Co (NYSE:MKC) reported earnings two weeks ago on October 2nd, 2014, an ...

Shares of Strayer Education Have Risen A...

Shares of Strayer Education (NASDAQ:STRA) traded today at $64.79, breaking its 52-week ...

Shares of Sonic Rise Above Previous 52-W...

Shares of Sonic (NASDAQ:SONC) traded today at $23.96, breaking its 52-week high. So fa ...

Shares of Sciclone Pharmaceuticals Rise ...

Shares of Sciclone Pharmaceuticals (NASDAQ:SCLN) traded at a new 52-week high today of ...

Shares of Regeneron Pharmaceuticals Rise...

Regeneron Pharmaceuticals (NASDAQ:REGN) traded today at a new 52-week high of $376.88. ...

Shares of RadNet Have Risen Above Previo...

Shares of RadNet (NASDAQ:RDNT) traded at a new 52-week high today of $8.72. Approximat ...

Recent 52-Week High Exceeded in Shares o...

The Pantry (NASDAQ:PTRY) traded today at a new 52-week high of $24.55. So far today ap ...

Nestle Looks to Continue to Trade Below ...

Shares of Nestle (NASDAQ:NSRGY) traded today at $65.79, breaking its 52-week low. This ...